The mechanism of action of aspirin — Is there anything beyond cyclo-oxygenase?
- 28 February 1995
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 44 (2) , 77-80
- https://doi.org/10.1016/0306-9877(95)90073-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antiplatelet therapy in the treatment of cerebrovascular diseaseClinical Cardiology, 1993
- A Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial InfarctionJAMA, 1980
- UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSISBritish Medical Bulletin, 1978
- Aspirin in coronary heart diseaseJournal of Chronic Diseases, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Regular Aspirin Intake and Acute Myocardial InfarctionBMJ, 1974
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962